Search for a report

EUROPE COUGH SYRUP MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • EUROPE COUGH SYRUP MARKET FORECAST 2021-2028

EUROPE COUGH SYRUP MARKET FORECAST 2021-2028

The Europe cough syrup market is forecasted to register a CAGR of 2.79% during the estimated period of 2021 to 2028. The increasing geriatric population, as well as the rising burden of respiratory diseases, are among the key factors accredited to the market growth of the region.

EUROPE COUGH SYRUP MARKET FORECAST 2021-2028

Europe Cough Syrup Market by Product Type (Cough Suppressants/antitussives, Combination Medications, Expectorants) Market by Age Group (Adult, Pediatric) Market by Distribution Channels (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy) by Geography.

Request free sample

The Europe cough syrup market is forecasted to register a CAGR of 2.79% during the estimated period of 2021 to 2028. The increasing geriatric population, as well as the rising burden of respiratory diseases, are among the key factors accredited to the market growth of the region.europe-cough-syrup-market

To learn more about this report, request a free sample copy

The Europe cough syrup market growth study includes the analysis of Poland, the United Kingdom, France, Russia, Belgium, Italy, Germany, and the rest of Europe. Air pollution continues to be a significant health concern in the United Kingdom. Besides, the health impacts of air pollution in the country are associated with an extensive range of health conditions and diseases like lung cancer, heart disease, and strokes. Respiratory ailments are the third leading cause of mortality in the United Kingdom, including chronic obstructive pulmonary disease (COPD) and asthma. Moreover, as per the British Lung Foundation, approximately 10,000 people in the country are diagnosed with lung disease, weekly.

Conversely, chronic obstructive pulmonary disease (COPD) has a relatively high incidence rate in Germany. According to industry sources, while 10% to 15% of German adults suffer from chronic bronchitis, up to 15% of children, as well as 5% to 7% of the adult population, are diagnosed with bronchial asthma. Furthermore, lung diseases are the fourth-highest cause of death in the country. Hence, these factors are set to fuel the Europe cough syrup market over the forecast period.

Novartis International AG, headquartered in Switzerland, researches, markets, develops, and manufactures healthcare products. The company entails two global operation divisions, namely, Sandoz and Innovative Medicines. Sandoz offers active ingredients as well as finished dosage forms of pharmaceuticals in areas such as cardiovascular, dermatology, oncology, ophthalmic, and others. Alternatively, the Innovative Medicines division provides patented prescription medicines and commercializes products in oncology and rare diseases, immunology and dermatology, etc.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • RISING GERIATRIC POPULATION
        • INCREASE IN CHRONIC RESPIRATORY DISEASES
      • KEY RESTRAINTS
        • OVERDOSE RISKS ASSOCIATED WITH COUGH SYRUP
        • GOVERNMENT REGULATIONS AND RESTRICTIONS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON COUGH SYRUP MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY PRODUCT TYPE
      • COUGH SUPPRESSANTS/ANTITUSSIVES
      • COMBINATION MEDICATIONS
      • EXPECTORANTS
    3. MARKET BY AGE GROUP
      • ADULT
      • PEDIATRIC
    4. MARKET BY DISTRIBUTION CHANNELS
      • RETAIL PHARMACY
      • HOSPITAL PHARMACY
      • ONLINE PHARMACY
    5. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY DRIVERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PARTNERSHIPS & AGREEMENTS
      • COMPANY PROFILES
        • ABBOTT LABORATORIES
        • ACELLA PHARMACEUTICALS LLC
        • ASTRAZENECA PLC
        • CIPLA LIMITED
        • DABUR INDIA LTD
        • GLAXOSMITHKLINE PLC
        • GLENMARK PHARMACEUTICAL LIMITED
        • JOHNSON & JOHNSON
        • MERCK KGAA
        • NOVARTIS INTERNATIONAL AG
        • PFIZER INC
        • PROCTOR & GAMBLE CO (P&G)
        • RECKITT BENCKISER GROUP PLC
        • SANOFI SA
        • THE HIMALAYA DRUG COMPANY

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – COUGH SYRUP

    TABLE 2: THE COUNTRIES WITH THE LARGEST PERCENTAGE OF TOTAL POPULATION OVER 65 YEARS, IN 2020

    TABLE 3: EUROPE COUGH SYRUP MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 4: EUROPE COUGH SYRUP MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 5: EUROPE COUGH SYRUP MARKET, BY AGE GROUP, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 6: EUROPE COUGH SYRUP MARKET, BY AGE GROUP, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 7: EUROPE COUGH SYRUP MARKET, BY DISTRIBUTION CHANNELS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 8: EUROPE COUGH SYRUP MARKET, BY DISTRIBUTION CHANNELS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 9: EUROPE COUGH SYRUP MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 10: EUROPE COUGH SYRUP MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 11: KEY PLAYERS IN EUROPE COUGH SYRUP MARKET

    TABLE 12: LIST OF MERGERS & ACQUISITIONS

    TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: EUROPE COUGH SYRUP MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2020

    FIGURE 6: EUROPE COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS/ANTITUSSIVES, 2021-2028 (IN $ MILLION)

    FIGURE 7: EUROPE COUGH SYRUP MARKET, BY COMBINATION MEDICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 8: EUROPE COUGH SYRUP MARKET, BY EXPECTORANTS, 2021-2028 (IN $ MILLION)

    FIGURE 9: EUROPE COUGH SYRUP MARKET, GROWTH POTENTIAL, BY AGE GROUP, IN 2020

    FIGURE 10: EUROPE COUGH SYRUP MARKET, BY ADULT, 2021-2028 (IN $ MILLION)

    FIGURE 11: EUROPE COUGH SYRUP MARKET, BY PEDIATRIC, 2021-2028 (IN $ MILLION)

    FIGURE 12: EUROPE COUGH SYRUP MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNELS, IN 2020

    FIGURE 13: EUROPE COUGH SYRUP MARKET, BY RETAIL PHARMACY, 2021-2028 (IN $ MILLION)

    FIGURE 14: EUROPE COUGH SYRUP MARKET, BY HOSPITAL PHARMACY, 2021-2028 (IN $ MILLION)

    FIGURE 15: EUROPE COUGH SYRUP MARKET, BY ONLINE PHARMACY, 2021-2028 (IN $ MILLION)

    FIGURE 16: EUROPE COUGH SYRUP MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 17: UNITED KINGDOM COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 18: GERMANY COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 19: FRANCE COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 20: ITALY COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 21: RUSSIA COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 22: BELGIUM COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 23: POLAND COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 24: REST OF EUROPE COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY DRIVERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. MARKET BY PRODUCT TYPE
      • COUGH SUPPRESSANTS/ANTITUSSIVES
      • COMBINATION MEDICATIONS
      • EXPECTORANTS
    2. MARKET BY AGE GROUP
      • ADULT
      • PEDIATRIC
    3. MARKET BY DISTRIBUTION CHANNELS
      • RETAIL PHARMACY
      • HOSPITAL PHARMACY
      • ONLINE PHARMACY

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now